Reference
Tanaka J, et al. Economic impact of HCV treatment - Japan, 2015-2030. The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases : abstr. 1048, 20 Oct 2017. Available from: URL: http://onlinelibrary.wiley.com/doi/10.1002/hep.29501/epdf
Rights and permissions
About this article
Cite this article
Potential to reduce economic burden of HCV in Japan. PharmacoEcon Outcomes News 791, 25 (2017). https://doi.org/10.1007/s40274-017-4509-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4509-3